期刊文献+

Treg/Th17细胞分化失衡与炎症性肠病 被引量:4

Imbalance of Treg/Th17 Cells Differentiation and Inflammatory Bowel Disease
下载PDF
导出
摘要 炎症性肠病(IBD)的病因和发病机制尚未完全明确,初始CD4^+T细胞分化异常在其发生、发展过程中起重要作用。初始CD4^+T细胞可分化为调节性T细胞(Treg细胞)和Th17细胞,Treg/Th17细胞间的失衡将导致包括IBD在内的多种自身免疫病的发生。初始CD4^+T细胞周围的细胞因子和芳香烃受体对维持该平衡起重要作用。本文就Treg细胞和Th17细胞及其与IBD的关系作一综述。 The etiology and pathogenesis of inflammatory bowel disease(IBD) have not been well clarified,the abnormal differentiation of naive CD4~+ T cells is believed to play a critical role in the development of IBD.Naive CD4~+ T cells can differentiate into regulatory T cells(Treg cells) and Th17 cells,the imbalance of Treg/Th17 cells will cause various kinds of autoimmune disease including IBD.Cytokines around the naive CD4~+ T cells and aryl hydrocarbon receptor play important roles in maintaining the balance.This article reviewed Treg cells,Th17 cells and their relationship with IBD.
出处 《胃肠病学》 2011年第8期499-502,共4页 Chinese Journal of Gastroenterology
关键词 T淋巴细胞 调节性 T淋巴细胞 辅助诱导 炎症性肠病 细胞因子类 T-Lymphocytes Regulatory T-Lymphocytes Helper-Inducer Inflammatory Bowel Disease Cytokines
  • 相关文献

参考文献37

  • 1Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 2006, 441 (7090): 235-238.
  • 2Chen Z, Lin F, Gao Y, et al. FOXP3 and RORγt: transcriptional regulation of Treg and Th17. Int Immunopharmacol, 2011, 11 (5): 536-542.
  • 3Beissert S, Schwarz A, Schwarz T. Regulatory T cells. J Invest Dermatol, 2006, 126 (1): 15-24.
  • 4Izcue A, Coombes JL, Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev, 2006, 212: 256-271.
  • 5Bi Y, Liu G, Yang R. Reciprocal modulation between TH17 and other helper T cell lineages. J Cell Physiol, 2011, 226 (1): 8-13.
  • 6Murai M, Turovskaya O, Kim G, et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol, 2009, 10 (11): 1178- 1184.
  • 7Valencia X, Stephens G, Goldbach-Mansky R, et al. TNF downmodulates the function of human CD4+CD25hi T- regulatory cells. Blood, 2006, 108 (1): 253-261.
  • 8Nistala K, Wedderbum LR. Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology (Oxford), 2009, 48 (6): 602-606.
  • 9Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T (H)17 cells. Nature, 2007, 448 (7152): 484-487.
  • 10Yang XO, Pappu BP, Nurieva R, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity, 2005, 28 (1): 29-39.

二级参考文献27

  • 1Wen Z,Fiocchi C.Inflammatory bowel disease:autoimmune or immune-mediated pathogenesis? Clin Dev Immunol,2004,11 (3-4):195-204.
  • 2Maul J,Loddenkemper C,Mundt P,et al.Peripheral and intestinal regulatory CD4 + CD25 (high) T cells in inflammatory bowel disease.Gastroenterology,2005,128 (7):1868-1878.
  • 3Saruta M,Yu QT,Fleshner PR,et al.Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease.Clin Immunol,2007,125 (3):281-290.
  • 4Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3.Science,2003,299 (5609):1057-1061.
  • 5Rachmilewitz D.Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis:a randomised trial.BMJ,1989,298 (6666):82-86.
  • 6Annunziato F,Cosmi L,Santarlasci V,et al.Phenotypic and functional features of human Th17 cells.J Exp Med,2007,204 (8):1849-1861.
  • 7Mottet C,Uhlig HH,Powrie F.Cutting edge:cure of colitis by CD4+CD25+ regulatory T cells.J Immunol,2003,170 (8):3939-3943.
  • 8Powrie F.Immune regulation in the intestine:a balancing act between effector and regulatory T cell responses.Ann N Y Acad Sci,2004,1029:132-141.
  • 9Maloy KJ,Salaun L,Cahill R,et al.CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.J Exp Med,2003,197 (1):111-119.
  • 10Yu QT,Saruta M,Avanesyan A,et al.Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.Inflamm Bowel Dis,2007,13 (2):191-199.

共引文献22

同被引文献78

  • 1张艳丽,黄循铷,王承党.小鼠葡聚糖硫酸钠急性溃疡性结肠炎模型的建立和评价[J].胃肠病学和肝病学杂志,2006,15(2):130-133. 被引量:28
  • 2李毓,骆芳.针灸治疗对溃疡性结肠炎患者细胞因子的影响[J].新疆中医药,2007,25(2):21-23. 被引量:9
  • 3Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease[J]. Gut, 2004, 53 (1): 1-4.
  • 4Lopez-Siles M, Khan TM, Duncan SH, et al. Gut environ- mental factors may shape the persistence of Faecalibacterium prausnitzii in the healthy and diseased large intestine [ J ]. Gastroenterology, 2011, 140(5) : $665.
  • 5Machiels K, Joossens M, De Preter V, et al. Association of Faecalibacterium prausnitzii and disease activity in ulcerative colitis[J]. Gastroenterology, 2011, 140 (5): S142.
  • 6Varela E, Antolin M, Manichanh C, ct al. Colonization by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis [ J ]. Gastroen- terology, 2011, 140 (5) : S47.
  • 7Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients[J]. Proc Natl Acad Sci U S A, 2008, 105 (43) : 16731-16736.
  • 8van Hemert S, Meijerink M, Molenaar D, et al. Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells [ J ]. BMC Microbiol, 2010, 10: 293.
  • 9Sokol H, Seksik P, Furet JP, et al. Low counts of Faeca-libacterium prausnitzii in colitis microbiota [ J ]. Inflamm Bowel Dis, 2009, 15 (8) : 1183-1189.
  • 10Kaibullayeva J, Abilaiuly S, Nersesov A. Relationship between cytokine profile and local immunity in ulcerative colitis[J]. J Crohns Colitis, 2011, 5 (1): S64.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部